NCT05029583View on ClinicalTrials.gov

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

NARecruitingINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

August 11, 2021

Primary Completion Date

October 5, 2025

Study Completion Date

October 5, 2025

Conditions
Nonalcoholic SteatohepatitisType 2 Diabetes
Interventions
OTHER

routine screening

routine screening for advanced NASH

OTHER

physician-driven screening

physician-driven screening for advanced NASH

Trial Locations (1)

M4G 3E8

RECRUITING

LMC Diabetes & Endocrinology Ltd., Toronto

All Listed Sponsors
lead

LMC Diabetes & Endocrinology Ltd.

OTHER